2nd Circ. Throws Out Appeal Of Lipitor FCA Dismissal
The Second Circuit on Wednesday refused to revive a False Claims Act suit over Pfizer Inc.'s alleged off-label marketing of the popular cholesterol drug Lipitor, finding it lacked jurisdiction to consider...To view the full article, register now.
Already a subscriber? Click here to view full article